Integrating medicine, engineering and business to educate early-stage researchers in cardiovascular device development

Vizgan, Gabriel; Hill-Whilton, Zachary; Gillespie, Colleen; Cobos, Daniel; Johnson, LeAnn; Dib, Nabil; Simson, Gabrielle Gold‐von

doi:10.1038/s41587-022-01498-6

Cited by 2 publications

(3 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Furthermore, educational programs offered by TTOs provide segmented consultation and insights into considerations for commercialization. Further incorporation of entrepreneurial education into biomedical curricula could enhance the effectiveness of tech transfer programs, as has been shown with the effectiveness of prior programs devoted to biomedical entrepreneurial education (Vizgan et al, 2022 , 2023 ; Eidlisz et al, 2024 ).…”

Section: Discussionmentioning

confidence: 97%

“…. entrepreneurial education (Vizgan et al, 2022(Vizgan et al, , 2023Eidlisz et al, 2024). The commercialization journey takes several years and requires meticulous planning and iterative adjustments.…”

Section: Discussionmentioning

confidence: 99%

“…Improvements in TT interfaces can streamline the process, making it easier for biomedical innovators to navigate the path to market. Education and training for early-stage researchers and founders equips them with the knowledge and skills needed to overcome hurdles in the complex biotechnology and medical device commercialization process and has been shown to improve competency in entrepreneurship and commercialization (Vizgan et al, 2022 , 2023 ; Eidlisz et al, 2024 ). Additionally, increased support from academic institutions and other partnerships can provide the resources and backing necessary for success (Siontorou and Batzias, 2010 ; Hait and Stoffels, 2021 ).…”

Section: Challenges and Solutionsmentioning

confidence: 99%

See 2 more Smart Citations

Exploring the current state of technology transfer in the United States: perspectives and improvement strategies from the experts

Eidlisz,

von Simson,

Gold-von Simson

2024

Front. Res. Metr. Anal.

Self Cite

View full text Add to dashboard Cite

Technology transfer (TT) is a necessary, yet complex process to convey and disseminate scientific knowledge to the commercial sector. However, multiple barriers in TT can impede commercialization and innovative progress. To cultivate a deeper understanding, we conducted five interviews with strategic, elite leaders in different areas of TT in the United States. Experts shared their perspectives on the current state of TT, what needs improvement, and potential solutions to enhance the TT landscape, with a focus on biotechnology and medical devices. The formation of strong management teams, a comprehension of the regulatory, reimbursement, and funding pathways and policies, and thorough market assessments were noted as key aspects for venture success. Collaboration with Technology Transfer Offices (TTOs), industry experts, and strategic partners are also essential to support academic innovators and guide them throughout the complex commercialization process. There is agreement that a venture should have a defined vision and clear goals with a robust business case for the innovation; early involvement of TTOs is essential. Comprehension of the complexities and key facets of TT, while also streamlining the process, will better position biomedical innovators for success.

show abstract

Section: Discussionmentioning

confidence: 97%

Section: Discussionmentioning

confidence: 99%